France· FR:67563415
BURINEX 5 mg, comprimé
A bumetanide product containing bumétanide, registered in France by KARO PHARMA (SUEDE), on the national reimbursement list. The same ATC class is registered in 10 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Bumetanide is registered in 10 of 19 countries.
Countries holding a registration under ATC C03CA02 (bumetanide), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 5 of them publish a price we can compare per daily dose
Bumetanide · ATC C03CA02
10 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Franceprice
- Ireland
- Netherlands
- Norwayprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of bumetanide costs, country by country.
Normalised to the WHO defined daily dose (1 mg), so markets compare like for like.
- France: $0.13 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Bumetanide · price per daily dose (1 mg)
USD · FX 28 Sept 2026
- FR France$0.13
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- BUMÉTANIDE
- Manufacturer
- KARO PHARMA (SUEDE)
- Country
- France (FR)
- ATC code
- C03CA02
- ATC class
- Bumetanide
- Defined daily dose
- 1 mg, O
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400934521393film(s) thermosoudé(s) aluminium de 30 comprimé(s)EUR 15.15
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
318 interactions on record for bumetanide.
Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Bumetanide · interactions on record
318 records
- 15 severe
- 177 moderate
- 9 minor
- 116 info
Most severe, free to view
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- NeomycinA07AA01severe
- StreptomycinA07AA04severe
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Bumetanide in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBumetanide 5mg tabletsAlliance Healthcare (Distribution) Ltd
- NetherlandsBumetanide CF 5 mg, tablettenCentrafarm B.V.
- NorwayBurinexKaro Pharma AB (1)
- CanadaBURINEXKARO PHARMA AB
- IrelandBurinex 5 mg TabletsKaro Pharma AB
- United StatesbumetanideHeritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- SwedenBurinex 0,5 mg/ml Injektionsvätska, lösningKaro Pharma AB
- FinlandBurinexLeo Pharma A/S
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Austria · Burinex
- Belgium · Burinex
- Denmark · Burinex
- Spain · Fordiuran
- United Kingdom (Northern Ireland) · Bumetanide Generics Uk, Bumetanide Niche Generics
- Greece · Burinex
- Ireland · Burinex
- Luxembourg · Burinex
- Malta · Burinex
- Netherlands · Bumetanide Cf, Bumetanide Sandoz
- Norway · Burinex
- Sweden · Burinex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f4258f6d-c3db-43c3-b88d-4a6505a3679e GET /v1/drugs/f4258f6d-c3db-43c3-b88d-4a6505a3679e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "67563415",
"date_amm": "1989-09-28",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "BUMÉTANIDE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about bumetanide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.